CRH plc CRH presents investors with a valuation-versus-execution decision. Better-than-expected second-quarter results, sizable infrastructure exposure and reaffirmed 2026 guidance support the case for the shares.
The offsets are meaningful. Subdued U.S. new-build housing, inflationary costs and acquisition-related capital demands argue for a measured approach rather than an aggressive entry.
CRH’s Valuation Offers a Relative Discount
CRH’s forward 12-month price-to-earnings ratio is 15.32, below 18.41 for its Zacks sub-industry, 20.3 for the Zacks Construction sector and 20.71 for the S&P 500. The spread supports the relative-valuation argument.
The stock is not unusually cheap relative to its own history. Its five-year median multiple is 14.58, below the current level, which tempers the apparent discount and keeps execution central to the valuation case.
CRH’s Earnings Beat Supports the Bull Case
Second-quarter adjusted earnings of $2.21 per share topped the Zacks Consensus Estimate of $1.96 by 12.8% and increased 14% year over year. Revenues rose 6% to $10.78 billion and exceeded the consensus mark by 0.5%.
CRH also reaffirmed 2026 adjusted EBITDA guidance of $8.1-$8.5 billion and earnings guidance of $5.60-$6.05 per share. The outlook assumes favorable demand across key end markets, while new-build residential activity remains subdued.
CRH’s Infrastructure Mix Supports Demand
Infrastructure represented 40% of CRH’s fiscal 2025 end-market exposure, giving the company substantial participation in public construction spending. Management said about 40% of U.S. Infrastructure Investment and Jobs Act funding remained unspent in 2026, supporting momentum into 2027.
Transportation, water and reindustrialization remain important demand drivers. Martin Marietta Materials, Inc. MLM, another large U.S. aggregates supplier, reported 16% year-over-year growth in second-quarter 2026 aggregates revenues, although acquisitions contributed significantly to shipment growth. Vulcan Materials Company VMC, the nation’s largest producer of construction aggregates, reiterated its 2026 adjusted EBITDA outlook of $2.4-$2.6 billion after reporting second-quarter results, providing another reference point for the aggregates market.
CRH Still Faces Housing and Cost Pressure
Americas Building Solutions revenues declined 2% in the second quarter to $2.12 billion. Adjusted EBITDA fell 8% to $462 million and margin contracted 140 basis points to 21.8%, as divestitures, subdued residential demand and cost inflation weighed on performance.
Housing is not the only constraint. CRH continues to face elevated costs, including haulage expenses, while the planned Arcosa acquisition adds financing and integration requirements. Net debt was $15.4 billion at June 30, 2026, up from $14.2 billion at year-end 2025, and CRH paused new share-buyback tranches after announcing the deal.
CRH’s Mixed Scores Favor a Balanced View
CRH’s operating and valuation positives are credible, but the risk-reward setup does not point to an aggressive buy. The stock currently carries a Zacks Rank #3 (Hold), which supports a patient stance while investors watch housing conditions, cost control and acquisition execution. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The company has a Value Score of B, Growth Score of C, Momentum Score of F and VGM Score of C. The Value Score supports the relative-valuation case, but the weaker Momentum Score and middling Growth and VGM Scores suggest that valuation alone is not enough to make the near-term setup compelling.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Â
Â
Â


(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.